| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226386.1 |
Tanespimycin |
Esophageal cancer |
0.016258508 |
Resistant |
| ENSG00000226386.1 |
Tanespimycin |
Kidney renal clear cell carcinoma |
0.024257576 |
Resistant |
| ENSG00000226386.1 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.029400545 |
Resistant |
